Antidepressant Cuts COVID-19 Hospitalizations by up to 73 Percent

A 10-day course of the inexpensive antidepressant fluvoaxamine cut the risk of COVID-19-related hospitalization by 32 percent in infected patients with comorbidities, a research team in Brazil has found.
Source: Drug Industry Daily